by admin | Nov 27, 2023 | Events
The event raised critical questions about the prioritization of maternal health and the potential impact on global health priorities from a gender lens and as a question of gender equality, discussing why despite the preventability of PPH-related deaths, progress has stagnated. The forum, following the recent launch of a Global Roadmap by WHO and partners, delved into examining gender, health, and leadership, addressing the persisting challenges in global efforts to combat PPH-related maternal mortality. The perspectives of care from the field, including insights from a midwife from the Philippines, amplified the priorities and highlighted how supporting the women’s health agenda and investing in women’s groups and agencies can have a notable impact.
Learn more about this event here.
Watch the event here.
by admin | Nov 17, 2023 | Events
A presentation by GENDRO at the Conference on Sex and Musculoskeletal Research focused on the role of SAGER guidelines in fostering greater attention to sex and gender across disciplines, welcoming any measures for adoption of the SAGER guidelines by the journals in the field, encouraging editors to play a more active role in its uptake and using the guidelines as tool to promote greater attention of the sex and gender dimensions across the research ecosystem.
Read more here.
by admin | Sep 27, 2023 | Events
The Global Launch of the Commission report on Women, Power, and Cancer, was co-hosted by GENDRO, alongside other partners, at the Geneva Graduate Institute. The report investigates the intersection of women, power, and cancer, beyond the scope of “women’s cancers” and explores various aspects of cancer experiences among women, considering factors such as gender bias and discrimination based on age, race, ethnicity, socio-economic status, sexual orientation, and gender identity. The Lancet Commission’s approach is firmly grounded in intersectional feminism. This framework places women’s concerns, voices, and needs at the core of its work. Importantly, this approach doesn’t exclude men but aims to generate evidence that truly reflects the complexity and diversity of women’s experiences.
The launch event featured presentations of key findings and recommendations, by Dr Ophira Ginsburg, NICC, Lead Commissioner, aimed at inspiring real-world action for transformational change. Following her, Dr Shirin Heidari, president of GENDRO and a commissioner to the report, offered remarks on the critical contribution of the intersectional feminist approach to advancing cancer research, prevention, diagnosis and care. She emphasized the need to bring feminism back into conversations about health, especially cancer. Feminism can serve as a powerful lens through which to examine health disparities, and strive for social change and justice.
Distinguished speakers joining the panels, included Ophira Ginsburg, Shirin Heidari, Isabelle Soerjomataram, Verna Vanderpuye, Nirmala Bhoo-Pathy, Somesh Kumar, Jennifer Moodley, Karla Unger-Saldaña, Jérôme Salomon, Monica Bertagnolli, Kalipso Chalkidou, Lynette Denny, Bente Mikkelsen, and Micaela Serafini facilitated by Vania Coelho Wisdom and Richard Horton, The Lancet.
Event website: here.
Recording: (Embed): https://www.youtube.com/watch?v=3QFGdyGJD_0
Commission Report: here.
The Commission website: https://womenandcancercommission.org
by admin | Feb 2, 2023 | Events
2 February 2023 | Organisers: GENDRO and CIOMS
GENDRO and CIOMS jointly convened a meeting with key stakeholders, including the World Medical Association, Council of Europe, World Health Organization, representatives from research ethics committees, research institutions, and the pharmaceutical industry. The focus was on the crucial role of Research Ethics Committees (RECs) in addressing gender bias in research with human participants, using the SAGER guidelines as a valuable tool. CIOMS’ Secretary General Dr. Lembit Rägo initiated a dialogue on the role of RECs in strengthening sex and gender considerations in health research. GENDRO’s President, Dr. Shirin Heidari, underscored the concern of inadequate incorporation of sex and gender considerations in research and credited the success of the SAGER guidelines in raising awareness and improving reporting. Emphasizing the responsibility of every gatekeeper in the research ecosystem, including RECs, Dr. Heidari stressed the need for proper integration of sex and gender considerations throughout health research.
Dr. Abha Saxena, an independent bioethicist, presented findings from a scoping review conducted as part of GENDRO’s working group on gender and research ethics, revealing a lack of evidence on sufficient attention to sex and gender dimensions in the work of RECs.
The meeting facilitated consensus-building on the importance of a unified approach among all stakeholders in the research ecosystem to enhance the inclusion and meaningful consideration of sex and gender in research. The meeting concluded with proposed actions and a collaborative path forward, committed to by GENDRO and CIOMS.
Read the full report here.
by Gendro | Sep 1, 2018 | Events
GENDRO’s president, Dr. Heidari, described the harmful implications of gender bias in global health data and research, and offered a path to change the paradigm towards programs relevant for everyone.
